News

Regulatory NewsRegulatory Round-up - December 2024
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2025202420232022 →
Press release: New data from Cell and Gene Therapy Catapult report shows move towards commercialisation and 48% increase in GMP manufacturing space despite COVID-19 pandemicPress release: New data from Cell and Gene Therapy Catapult report shows move towards commercialisation and 48% increase in GMP manufacturing space despite COVID-19 pandemicPost-Brexit transition guidance for the cell and gene therapy industryPost-Brexit transition guidance for the cell and gene therapy industryRegulatory News - October 2020Regulatory News - October 2020Procurement process open for the development of ATSTN National Training CentresProcurement process open for the development of ATSTN National Training CentresOctober newsletter: Driving the clinical adoption of cell and gene therapiesOctober newsletter: Driving the clinical adoption of cell and gene therapiesCelebrating the achievements of the Advanced Therapies Apprenticeship CommunityCelebrating the achievements of the Advanced Therapies Apprenticeship CommunityPress Release: CGT Catapult appoints two new Board membersPress Release: CGT Catapult appoints two new Board membersPress Release: Stevenage named High Potential Opportunity zone for Cell and Gene TherapyPress Release: Stevenage named High Potential Opportunity zone for Cell and Gene TherapyRegulatory News - September 2020Regulatory News - September 2020Press Release: CGT Catapult appoints Dr Nick Johnson as Chief Strategy and Impact OfficerPress Release: CGT Catapult appoints Dr Nick Johnson as Chief Strategy and Impact OfficerPress release: CombiGene and CGT Catapult collaboration completes development of quality control analytical assays for clinical production of CombiGene’s AAV-based gene therapy for the treatment of epilepsyPress release: CombiGene and CGT Catapult collaboration completes development of quality control analytical assays for clinical production of CombiGene’s AAV-based gene therapy for the treatment of epilepsyAdvanced Therapy Treatment Centre network awarded £9.5m further investmentAdvanced Therapy Treatment Centre network awarded £9.5m further investment